The Revised Cardiac Risk Index (RCRI) is a Useful Tool for Evaluation of Perioperative Cardiac Morbidity in Kidney Transplant
These guidelines suggest that preoperative cardiac testing is justified because it is difficult to quantify cardiovascular risk based on patient history alone. Although risk stratification indices have been published, few have been tested on this unique patient population (7) . One such stratification tool, the "Revised Cardiac Risk Index (RCRI)" (8) , is a commonly used, well validated, simple and practical stratification tool.
Evidence based risk stratification of renal transplant patients could help guide perioperative medical management, potentially improving safety and reducing cost.
This study aims to determine whether the RCRI can predict major cardiovascular morbidity in the renal transplant patients, and to determine which of the RCRI preoperative risk factors are most strongly associated with adverse cardiac events.
Results
Baseline patient characteristics are presented in Table 1 . The total incidence of cardiac complications in the study population was 7.1% (23/325). All of these patients were on dialysis at the time of transplant. The cardiac safety endpoints included death, myocardial infarction, congestive heart failure, complete heart block, ventricular fibrillation, and elevated troponin. Of the 23 patients who had an adverse cardiac event, three died; one patient died from coronary in-stent thrombosis, and two patients died from a myocardial infarction in the setting of overwhelming sepsis. The remaining 20 patients with cardiac complications had either a non-ST elevation myocardial infarction, congestive heart failure, or an isolated elevated troponin (n=5), with only 3 requiring any postoperative invasive coronary intervention (Table 2 ).
An increasing number of RCRI preoperative risk factors was significantly associated with higher rates of perioperative cardiac complications (ROC area 0.77, p<0.0001).
When stratified by patient age, this significant association was again seen for patients age ≥ 50y (ROC area 0.77, p<0.0001), but not for patients <50y in whom only 2 complications occurred ( Figure 1 ). contributed to the prediction of cardiovascular morbidity with roughly equal weight, such was not the case in our kidney transplant population. CAD was most strongly associated with cardiovascular morbidity, as would be expected. Unexpectedly, CHF came in a distant second, perhaps because pulmonary edema was more a function of fluid overload in a dialysis patient rather than secondary to acute myocardial ischemia or dysfunction. IDDM did not significantly predict excess risk, but a strong trend suggested that the study might have been underpowered to detect the association.
History
Gender and age, two historical risk factors for developing cardiovascular disease, were also evaluated for their predictive effects in the kidney transplant population (9) . Too few cardiovascular complications occurred in patients <50yrs of age to determine any meaningful association between risk factors and cardiovascular morbidity. The results of this study do however suggest that younger patients without a history of CAD or CHF are unlikely to suffer from cardiovascular complications. Interestingly, although men had more cardiovascular complications than women, once the confounding effects of other RCRI risk factors (such as CAD and CHF) were factored out, no statistical differences were seen between the sexes.
This study has several important limitations due to its retrospective design. First, it was not always apparent whether the preoperative diagnosis of CAD was made purely through history and physical exam or whether cardiac diagnostic testing played a role.
Second, patient selection criteria for cardiac testing were not standardized, and specific reasons for choosing to test were not always documented. Our institution follows the guidelines developed by the American Society of Transplantation (10) whereby all patients with potential cardiac symptoms or abnormal cardiac diagnostic tests are referred for evaluation by a transplant cardiologist, who then decides whether further cardiac testing is indicated. However, as a regional referral center our institution transplants patients from other institutions, which may utilize different algorithms to work up their patients preoperatively. Given this lack of standardization, it is possible that in some patients, cardiac diagnostic tests uncovered previously unknown CAD that would have been missed by risk factor evaluation alone. Furthermore, postoperative management and surveillance of cardiac complications were also not standardized.
Since electrocardiograms, serum troponin levels, and chest radiographs were not routinely ordered, silent myocardial ischemia might have been underreported. Given these limitations, we cannot recommend abandoning diagnostic testing on asymptomatic patients deemed at risk for coronary ischemia. Larger prospective trials would be needed to further develop perioperative best practice guidelines in the kidney transplant patient population.
Another limitation was that we did not analyze the coronary angiography results and correlate them to perioperative cardiac morbidity. However, our study was not designed to evaluate the perioperative ischemic risk of a specific coronary anatomy, as has previously been done (11) . Rather, its goal was to evaluate the utility of the RCRI in the kidney transplant population. We therefore set out to select a patient population with enough presumed high-risk subjects (and therefore anticipated cardiac complications)
to enable a meaningful statistical analysis; the coronary angiography subgroup in retrospect met these goals. Nevertheless, our total number of complications, while not insignificant, was too low to perform a multivariate logistic regression, and therefore the effects of confounding variables could not be excluded.
Given these limitations, we cannot recommend that the RCRI be used to replace cardiac testing or determine organ allocation. Nevertheless, accurate risk stratification can help medical personnel identify high-risk patients that may benefit from increased perioperative monitoring combined with goal-directed cardiovascular therapy (12) . With careful titration of fluid balance and watchful monitoring of cardiac function, cardiac morbidity may be reduced. Further research needs to be conducted to determine the best perioperative management strategy for kidney transplant candidates with heart disease. Given that the number-one cause of patient death with a functioning transplant is cardiovascular disease (13), even a small reduction in cardiovascular morbidity can have a significant impact.
Materials and Methods
After obtaining Institutional Review Board approval for this retrospective study (IRB# 10- level of significance, we determined that we needed a study population of 325 patients.
Our study group included all patients (n=169) who underwent preoperative coronary angiography and an age and transplant year matched group (n=156), which did not undergo coronary angiography. Indications for coronary angiography included: 1) evidence of myocardial ischemia on non-invasive stress testing, 2) clinical suspicion based upon patient symptoms and/or multiple cardiovascular risk factors. The detailed chart review of each of these 325 cases focused on the pertinent preoperative history, intraoperative events, and postoperative course, as described below.
After collecting preoperative baseline characteristics we applied the previously published RCRI (8) to the entire study group, identifying the following six preoperative risk factors: coronary artery disease (CAD), congestive heart failure (CHF), cerebrovascular disease (CVA), insulin-dependent diabetes mellitus (IDDM), serum creatinine> 2mg/dL, and high risk (suprainguinal vascular abdominal) surgery. The perioperative record was reviewed for the development of the following cardiovascular complications, as defined in the RCRI study: myocardial infarction, cardiac arrest, congestive heart failure, complete heart block, and ventricular fibrillation. Myocardial infarction was defined as the development of pathologic Q waves (≥30 msec in duration and ≥0.1 mV in depth) in two or more contiguous precordial leads or two or more adjacent limb leads, or an elevation of creatine kinase MB isoenzyme levels (or total creatine kinase if measures of creatine kinase MB were not available) to at least two times the upper limit of the normal range (14) . Congestive heart failure was diagnosed as the presence of pulmonary rales, pulmonary congestion on chest radiograph, or the presence of a third heart sound. Complete heart block was defined as loss of atrioventricular conduction. Troponin levels were obtained at the discretion of the treating physician. Isolated perioperative elevated troponin (>0.04mg/dL) was also captured as a complication given its association with poor cardiovascular outcome (15, 16) . The perioperative course and 30 day outcome of the patients who had an adverse cardiac event was then investigated and described.
The total number of risk factors for each patient was compared with the occurrence of postoperative cardiac complications to identify a possible association. This comparison was also stratified by age (≥50y vs. <50y) to determine that variable's impact on this association. The bivariate relationship between each individual RCRI risk factor and the incidence of cardiac complication was then assessed. Finally, graft type (living vs.
deceased donor) and patient gender were analyzed as potential predictive factors in addition to those defined by the RCRI.
Statistical methods
The association between the number of risk factors and the occurrence of complications was assessed using Spearman correlation to test for trend. Prediction accuracy of using the RCRI for predicting the risk of cardiac complications was evaluated using the area under the receiver operator characteristic (ROC) curve. The bivariate relationship between each individual component of the RCRI and the odds of having a complication was assessed using logistic regression. In addition, the relationship between gender and graft type versus the odds of having a complication was assessed before and after adjusting for the number of risk factors using logistic regression. These results are reported as odds ratios with corresponding 95% confidence intervals under the above logistic models. 
